Bayer Aktiengesellschaft (BAYRY)
OTCMKTS: BAYRY · Delayed Price · USD
7.68
-0.04 (-0.52%)
May 8, 2024, 3:59 PM EDT - Market closed
Bayer Aktiengesellschaft Revenue
In the year 2023, Bayer Aktiengesellschaft had annual revenue of 47.64B EUR, a decrease of -6.11%. Revenue in the quarter ending December 31, 2023 was 11.86B EUR, a -1.15% decrease year-over-year.
Revenue (ttm)
47.64B EUR
Revenue Growth
-6.11%
P/S Ratio
0.59
Revenue / Employee
491,453 EUR
Employees
96,931
Market Cap
30.18B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | 43.55B | 3.96B | 10.00% |
Dec 31, 2018 | 39.59B | 4.57B | 13.05% |
Dec 31, 2017 | 35.02B | -11.75B | -25.13% |
Dec 31, 2016 | 46.77B | 445.00M | 0.96% |
Dec 31, 2015 | 46.32B | 4.09B | 9.67% |
Dec 31, 2014 | 42.24B | 2.08B | 5.18% |
Dec 31, 2013 | 40.16B | 397.00M | 1.00% |
Dec 31, 2012 | 39.76B | 3.23B | 8.85% |
Dec 31, 2011 | 36.53B | 1.44B | 4.10% |
Dec 31, 2010 | 35.09B | 3.92B | 12.58% |
Dec 31, 2009 | 31.17B | -1.75B | -5.32% |
Dec 31, 2008 | 32.92B | 533.00M | 1.65% |
Dec 31, 2007 | 32.39B | 3.43B | 11.84% |
Dec 31, 2006 | 28.96B | 1.59B | 5.82% |
Dec 31, 2005 | 27.36B | -2.37B | -7.98% |
Dec 31, 2004 | 29.74B | 1.22B | 4.27% |
Dec 31, 2003 | 28.52B | -467.00M | -1.61% |
Dec 31, 2002 | 28.98B | -3.30M | -0.01% |
Dec 31, 2001 | 28.99B | -573.55M | -1.94% |
Dec 31, 2000 | 29.56B | 2.24B | 8.20% |
Dec 31, 1999 | 27.32B | -742.00M | -2.64% |
Dec 31, 1998 | 28.06B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
BAYRY News
- 20 hours ago - Bayer to unveil late-breaking data from Phase III OASIS 1 and 2 for elinzanetant in the treatment of vasomotor symptoms associated with menopause - Business Wire
- 5 days ago - FourKites, Bayer and Graphic Packaging International to Present at Gartner Supply Chain Symposium/Xpo 2024 - Business Wire
- 9 days ago - Bayer and Evotec Collaborate to Advance Precision Cardiology - Accesswire
- 12 days ago - Bayer CEO wins first AGM shareholder vote - Reuters
- 12 days ago - Bayer investor Deka takes a stand against CEO in annual vote - Reuters
- 14 days ago - Bayer Introduces Iberogast™ in the U.S., Bringing Proven Plant-Based Relief to the Millions Who Experience Gut Health Issues - Business Wire
- 16 days ago - Bayer confirms outlook despite slow businesses in agriculture, consumer health - Reuters
- 26 days ago - Bayer's patent for blood thinner Xarelto invalid, UK court rules - Reuters